Scholarlink

<p>Endophytic fungi are important sources of structurally diverse natural products with potential antifungal activity. In this study, four endophytic fungi were isolated from <i>Rosmarinus officinalis</i> and screened for bioactivity. An isolate identified as <i>Aspergillus candidus</i> was selected based on its antifungal profile, and its secondary metabolites were investigated. Cultivation in modified Czapek Yeast Broth followed by silica gel chromatography yielded a single major metabolite. Comprehensive GC–MS, FTIR, and 1D/2D NMR analysis established its structure as (2E, 7E)-6, 9-dihydroxy-10-(3-hydroxy-5-oxocyclohexyl) deca-2, 7-dien-1-yl acetate (C<sub>18</sub>H<sub>28</sub>O<sub>6</sub>, 340 Da), which, to the best of our knowledge, has not been previously reported in major chemical databases. Molecular docking and molecular dynamics simulations indicated a stable and plausible binding mode of this metabolite within the active site of <i>Candida albicans</i> lanosterol 14α-demethylase (CYP51), with docking validated using posaconazole as a reference inhibitor. In vitro antifungal testing by agar tube dilution showed modest but reproducible inhibition of <i>C. albicans</i> growth (15.5% and 24.3% inhibition at 500 and 1000&#xa0;µg/mL, respectively, vs. fluconazole control). Taken together, these findings identify a previously unreported <i>A. candidus</i> metabolite with confirmed antifungal activity and a mechanistically plausible interaction with CYP51, supporting its consideration as a scaffold for further optimization and detailed pharmacological evaluation rather than as a direct clinical candidate at this stage.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Purification and characterization of a dihydroxy Oxocyclohexyl acetate derivative from endophytic Aspergillus Candidus targeting Candida albicans lanosterol 14α-Demethylase

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月9日

查看全文
  • Ayesha Saleem,
  • Saeed Ullah Khattak,
  • Sajjad Ahmad,
  • Awais Ahmad,
  • Hatoon S. Alsagri,
  • Alaa Menshawi

摘要

Endophytic fungi are important sources of structurally diverse natural products with potential antifungal activity. In this study, four endophytic fungi were isolated from Rosmarinus officinalis and screened for bioactivity. An isolate identified as Aspergillus candidus was selected based on its antifungal profile, and its secondary metabolites were investigated. Cultivation in modified Czapek Yeast Broth followed by silica gel chromatography yielded a single major metabolite. Comprehensive GC–MS, FTIR, and 1D/2D NMR analysis established its structure as (2E, 7E)-6, 9-dihydroxy-10-(3-hydroxy-5-oxocyclohexyl) deca-2, 7-dien-1-yl acetate (C18H28O6, 340 Da), which, to the best of our knowledge, has not been previously reported in major chemical databases. Molecular docking and molecular dynamics simulations indicated a stable and plausible binding mode of this metabolite within the active site of Candida albicans lanosterol 14α-demethylase (CYP51), with docking validated using posaconazole as a reference inhibitor. In vitro antifungal testing by agar tube dilution showed modest but reproducible inhibition of C. albicans growth (15.5% and 24.3% inhibition at 500 and 1000 µg/mL, respectively, vs. fluconazole control). Taken together, these findings identify a previously unreported A. candidus metabolite with confirmed antifungal activity and a mechanistically plausible interaction with CYP51, supporting its consideration as a scaffold for further optimization and detailed pharmacological evaluation rather than as a direct clinical candidate at this stage.